ABDX.L

Abingdon Health Plc
LSEGBpEQUITY Healthcare DELAYED
Last price
11.00
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.65
Prev close
11.00
Day high
0.00
Day low
0.00
Volume
100.00K
Market cap
$27.80M
P/E (TTM)
52W range
0.00 – 13.00

Day trading desk

Current session · delayed
Gap from prior close
-3.18%
Prior close 11.00
VWAP
10.72
+2.64% from price
Relative volume
0.94×
Normal
Session range
9.52%
10.50 – 11.50
Position in range
50%
Mid range
ATR (14D)
0.99
8.97% of price
Prior day high
11.00
PDH
Prior day low
10.00
PDL
Bid / ask spread
Quote not published
Session volume
140.22K
Avg 149.13K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+4.76% +6.0%
1M
+12.82% +9.5%
3M
-8.33% -10.7%
6M
+62.96% +51.1%
YTD
+71.87% +59.9%
1Y
+83.33% +63.2%
3Y
+4.76% -70.2%
5Y
-81.61%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on ABDX.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
131.88M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
May 6, 26
Canaccord Genuity Group Inc.
1.43M Direct
Dec 3, 25
Garrett (Nina)
82.40K Direct
Dec 3, 25
Hand (Christopher William)
68.57K Direct
Dec 3, 25
Jones (Mark)
96.00K Direct
Dec 3, 25
Thrush (Natalie)
14.40K Direct
Dec 3, 25
Vendettuoli (Candice)
45.71K Direct
Dec 3, 25
Yates (Christopher Henry Francis)
205.71K Direct
Oct 31, 25
Canaccord Genuity Group Inc.
25.00M Direct
Oct 31, 25
CatenaLucis LLC
0 Direct
Oct 31, 25
NPIF YHTV Equity LP
0 Direct
Oct 31, 25
Thornapple LLP
0 Direct
Oct 31, 25
Yates (Christopher Henry Francis)
0 Direct
Oct 7, 25
Canaccord Genuity Group Inc.
0 Direct
Oct 7, 25
CatenaLucis LLC
0 Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
Canaccord Genuity Group Inc.
42.27M Decrease
CatenaLucis LLC
7.09M Holding
Hand (Christopher William)
13.25M Bought
Hargreaves Lansdown Asset Management Ltd.
10.13M Annual Return
Jones (Mark)
96.00K Bought
NPIF YHTV Equity LP
18.07M Holding
Octopus Investments Ltd
19.61M Annual Return
Rathbone Investment Management Ltd
13.94M Annual Return
Thornapple LLP
6.11M Holding
Yates (Christopher Henry Francis)
7.29M Bought

Fundamentals

TTM · reported
Market cap$27.80M
Enterprise value$44.91M
Revenue (TTM)$9.57M
Gross profit$3.96M
EBITDA$-3.42M
Net income$-3.24M
EPS (TTM)$-0.01
Free cash flow$-1.47M
Total cash$3.71M
Total debt$948.00K
Book value / share$0.02
Shares outstanding252.75M
Float168.65M
Short % of float
Dividend yield
Beta (5Y)0.13

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E220.00
PEG ratio
Price / sales
Price / book733.33
EV / revenue4.69
EV / EBITDA-13.13
Gross margin41.38%
Operating margin-53.88%
Profit margin-33.88%
Return on equity-50.98%
Return on assets-24.37%
Debt / equity15.05
Current ratio1.91
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $8.43M$6.13M$4.04M$2.83M +37.4%
Operating revenue $8.43M$6.13M$4.04M$2.83M +37.4%
Cost of revenue $4.69M$2.46M$1.97M$6.43M +91.1%
Gross profit $3.74M$3.68M$2.08M-$3.59M +1.5%
Selling, general & admin $7.71M$5.31M$5.22M$6.64M +45.2%
Total operating expense $7.25M$5.05M$5.69M$8.42M +43.4%
Operating income -$3.51M-$1.37M-$3.61M-$12.01M -155.6%
Net interest income $13.00K-$26.00K$14.00K-$65.00K +150.0%
Pre-tax income -$3.50M-$1.40M-$3.57M-$21.59M -149.9%
Tax provision -$81.00K-$128.00K-$105.00K-$331.00K +36.7%
Net income -$3.42M-$1.27M-$3.47M-$21.26M -168.7%
Net income to common -$3.42M-$1.27M-$3.47M-$21.26M -168.7%
Basic EPS -0.01-0.00-0.01-0.07 -121.4%
Diluted EPS -0.01-0.00-0.01-0.07 -121.4%
EBIT -$3.41M-$1.34M-$3.50M-$21.52M -154.0%
EBITDA -$2.80M-$916.00K-$2.81M-$19.89M -205.8%
Basic shares 366.66M304.74M304.03M291.62M +20.3%
Diluted shares 373.19M308.20M305.82M291.62M +21.1%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year -0.00 1 $10.90M +29.3%
Next year 0.00 1 $14.71M +34.9%

Analyst targets & ownership

Account required
Mean target$19.00
High target$19.00
Low target$19.00
Implied upside72.73%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders30.43%
Held by institutions31.57%
Institutions holding6
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
10.60
+3.77% from price
SMA 20
10.46
+5.16% from price
SMA 50
10.41
+5.68% from price
SMA 100
10.51
+4.63% from price
SMA 200
8.65
+27.17% from price
EMA 12
10.61
+3.72% from price
EMA 26
10.47
+5.05% from price
EMA 50
10.44
+5.38% from price
RSI (14)
81.5
Overbought
MACD (12,26,9)
0.13
Hist 0.07
ATR (14)
0.99
8.97% of price
Realised vol 30D
18.2%
Annualised
Bollinger upper
11.00
20, 2σ
Bollinger lower
9.92
20, 2σ
50 / 200 cross
Golden
10.41 vs 8.65
Trend bias
Above 200
+27.17%

Options chain

Account required
Expiry
Spot 11.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.16
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
18.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-28.6%
Peak to trough
Max drawdown 5Y
-94.0%
Peak to trough
ATR 14
0.99
8.97% of price
Beta (reported)
0.13
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.